MRI radiomics-based machine learning classification of atypical cartilaginous tumour and grade II chondrosarcoma of long bones

Atypical cartilaginous tumour (ACT) and grade II chondrosarcoma (CS2) of long bones are respectively managed with watchful waiting or curettage and wide resection. Preoperatively, imaging diagnosis can be challenging due to interobserver variability and biopsy suffers from sample errors. The aim of...

Full description

Saved in:
Bibliographic Details
Published inEBioMedicine Vol. 75; p. 103757
Main Authors Gitto, Salvatore, Cuocolo, Renato, van Langevelde, Kirsten, van de Sande, Michiel A.J., Parafioriti, Antonina, Luzzati, Alessandro, Imbriaco, Massimo, Sconfienza, Luca Maria, Bloem, Johan L.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.01.2022
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Atypical cartilaginous tumour (ACT) and grade II chondrosarcoma (CS2) of long bones are respectively managed with watchful waiting or curettage and wide resection. Preoperatively, imaging diagnosis can be challenging due to interobserver variability and biopsy suffers from sample errors. The aim of this study is to determine diagnostic performance of MRI radiomics-based machine learning in differentiating ACT from CS2 of long bones. One-hundred-fifty-eight patients with surgically treated and histology-proven cartilaginous bone tumours were retrospectively included at two tertiary bone tumour centres. The training cohort consisted of 93 MRI scans from centre 1 (n=74 ACT; n=19 CS2). The external test cohort consisted of 65 MRI scans from centre 2 (n=45 ACT; n=20 CS2). Bidimensional segmentation was performed on T1-weighted MRI. Radiomic features were extracted. After dimensionality reduction and class balancing in centre 1, a machine-learning classifier (Extra Trees Classifier) was tuned on the training cohort using 10-fold cross-validation and tested on the external test cohort. In centre 2, its performance was compared with an experienced musculoskeletal oncology radiologist using McNemar's test. After tuning on the training cohort (AUC=0.88), the machine-learning classifier had 92% accuracy (60/65, AUC=0.94) in identifying the lesions in the external test cohort. Its accuracies in correctly classifying ACT and CS2 were 98% (44/45) and 80% (16/20), respectively. The radiologist had 98% accuracy (64/65) with no difference compared to the classifier (p=0.134). Machine learning showed high accuracy in classifying ACT and CS2 of long bones based on MRI radiomic features. ESSR Young Researchers Grant.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2352-3964
2352-3964
DOI:10.1016/j.ebiom.2021.103757